azelaic acid 15% gel + azelaic acid 15% gel
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Papulopustular Rosacea
Conditions
Papulopustular Rosacea
Trial Timeline
Jan 1, 2007 → Jun 1, 2007
NCT ID
NCT00417937About azelaic acid 15% gel + azelaic acid 15% gel
azelaic acid 15% gel + azelaic acid 15% gel is a approved stage product being developed by Bayer for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT00417937. Target conditions include Papulopustular Rosacea.
What happened to similar drugs?
2 of 12 similar drugs in Papulopustular Rosacea were approved
Approved (2) Terminated (1) Active (9)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00417937 | Approved | Completed |
Competing Products
18 competing products in Papulopustular Rosacea